Retraction notice to "Volatile anesthetics sevoflurane targets leukemia stem/progenitor cells via Wnt/β-catenin inhibition" [Biomed. Pharmacother. 107 (2018), 1294-1301] [0.03%]
有关“挥发性麻醉剂异氟烷通过Wnt/β-catenin抑制作用针对白血病干细胞/祖细胞”[Biomed. Pharmacother. 107 (2018), 1294-1301]的撤稿通知
Xuguang Ruan,Weihang Jiang,Pingrui Cheng et al.
Xuguang Ruan et al.
Retraction notice to "Pinostrobin ameliorates lipopolysaccharide (LPS)-induced inflammation and endotoxemia by inhibiting LPS binding to the TLR4/MD2 complex" [Biomed. Pharmacother. 156 (2022) 113874] [0.03%]
撤销《_pinostrobin通过抑制LPS与TLR4 / MD2复合物结合来改善脂多糖（LPS）诱导的炎症和内毒素血症》[Biomed. Pharmacother. 156 (2022) 113874]
Athapaththu Mudiyanselage Gihan Kavinda Athapaththu,Kyeong Tae Lee,Mirissa Hewage Dumindu Kavinda et al.
Athapaththu Mudiyanselage Gihan Kavinda Athapaththu et al.
Retraction notice to "Moschus exerted protective activity against H2O2-induced cell injury in PC12 cells through regulating Nrf-2/ARE signaling pathways" [Biomedicine & Pharmacotherapy 159 (2023) 114290] [0.03%]
撤稿通知“Moschus通过调节Nrf-2/ARE信号通路对H2O2诱导的PC12细胞损伤发挥保护作用[Biomedicine & Pharmacotherapy（2023）159卷114290页]”
Danni Xie,Ting Deng,Zhenwei Zhai et al.
Danni Xie et al.
Retraction notice to "Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson's disease and cell culture via inactivating TLR4/NF-κB pathway" [Biomedicine & Pharmacotherapy 97 (2018) 1011-1019] [0.03%]
撤销《 juglanin 阿密留特明 LPS 诱导的神经炎症在帕金森病动物模型和细胞培养 via inactivating Tlr4/Nf-Kb Pathway》[Biomedicine & Pharmacotherapy 97 (2018) 1011-1019]
Fang-Xue Zhang,Ren-Shi Xu
Fang-Xue Zhang
Editorial for Brazilian papers [0.03%]
巴西报刊社论
Daniel Cristian,André Luis Branco de Barros
Daniel Cristian
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors [0.03%]
双链断裂的增加使肿瘤对氧化代谢抑制剂敏感
Ferran Medina-Jover,Agnès Figueras,Núria Gendrau-Sanclemente et al.
Ferran Medina-Jover et al.
Double-strand breaks (DSBs) accumulate in tumoral DNA due to deficiencies in homologous recombination (HR) repair, such as mutations in BRCA genes, or following antitumoral treatments. In the present study, we show that DSB accumulation, ir...
Retraction notice to "Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects" [Biomedicine & Pharmacotherapy 176 (2024) 116833] [0.03%]
撤稿通知：“揭示FOXO3在肺癌中的潜力：从分子见解到治疗前景”[Biomedicine & Pharmacotherapy 176 (2024) 116833]
Mohammad Ebrahimnezhad,Amir Valizadeh,Maryam Majidinia et al.
Mohammad Ebrahimnezhad et al.
Retraction notice to "Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme" [Biomedicine & Pharmacotherapy 141 (2021) 111928] [0.03%]
撤销《自然生物活性分子：治疗和控制多形性胶质母细胞瘤的替代方法》[Biomedicine & Pharmacotherapy 141 (2021) 111928]的通知
Priti Tagde,Pooja Tagde,Sandeep Tagde et al.
Priti Tagde et al.
Retraction notice to "Molecular insights to in vitro biocompatibility of endodontic Pulpotec with macrophages determined by oxidative stress and apoptosis" [Biomedicine & Pharmacotherapy 176 (2024) 116921] [0.03%]
有关根管材料Pulpotec与巨噬细胞体外生物相容性的分子见解的撤稿声明 [氧化应激和凋亡决定了牙髓组织学行为] [Biomedicine & Pharmacotherapy 176 (2024) 116921]
Ankita Mohanty,Swadheena Patro,Ealisha Jha et al.
Ankita Mohanty et al.
Retraction notice to "Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases" [Biomedicine & Pharmacotherapy 164 (2023) 114993] [0.03%]
关于撤回论文“非编码RNA介导的铁死亡在心血管疾病中的调节作用”[Biomedicine & Pharmacotherapy 164 (2023) 114993]的通知
Ying Liu,Wei Ding,Jianxun Wang et al.
Ying Liu et al.